Zejula

Zejula (Niraparib) is an oral prescription medication used for cancer treatment support. It belongs to the class of PARP inhibitors, aiding in managing certain conditions. This medication is taken as directed by a healthcare professional.

Zejula (Niraparib) is used to treat certain types of cancer by helping to slow or stop the growth of cancer cells. It is often prescribed for patients with ovarian cancer or other conditions where PARP inhibition may be beneficial. This medication works by targeting specific pathways in cancer cells.

Zejula may help reduce symptoms associated with certain cancers by targeting the underlying cellular processes. Patients may experience varied responses, and it is important to monitor any changes while taking this medication. Common effects can include gastrointestinal changes or fatigue.

Zejula should be handled with care, and patients should follow their healthcare provider’s instructions closely. It is important to store this medication safely and keep it out of reach of children. Regular check-ups may be necessary to monitor its effects.

Zejula may interact with other medications, including certain antidepressants, antifungals, or blood thinners. Alcohol and grapefruit products may also affect how this medication works. Always inform your healthcare provider about all medications and supplements you are taking.